Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Sugammadex in Renal Transplantation
NCT05187455Phase 4Unknown
- Sponsor
- General Hospital of Southern Theater Command of the People's Liberation Army
- Start
- Jan 2022
- Primary completion
- Nov 2022
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by General Hospital of Southern Theater Command of the People's Liberation Army. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT05187455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05187455.